1.
有手腕关节症状的SLE患者人口学及临床特点(n=69)
Demographic and clinical features in SLE patients with symptomatic hand and wrist joints (n=69)
| Demographic and clinical features | Data |
| SLEDAI, systemic lupus erythematosus disease activity index; ANA, antinuclear antibody; anti-dsDNA, anti-double-stranded DNA; anti-nRNP, anti-nuclear ribonucleoprotein; anti-SSA, anti-Sjögren’s syndrome A; anti-SSB, anti-Sjögren’s syndrome B; anti-rRNP, anti-ribosomal ribonucleoprotein; IgG, immunoglobulin G. | |
| Female, n (%) | 62 (88.5) |
| Age/years, x±s | 43.7±15.0 |
| Disease duration/years, median (min, max) | 6.0 (0.1, 40.0) |
| Joint involvement, n (%) | 55 (79.7) |
| Skin involvement, n (%) | 33 (47.8) |
| Raynaud’s phenomenon, n (%) | 5 (7.2) |
| Lupus nephritis, n (%) | 34 (49.2) |
| Neuropsychiatric lupus, n (%) | 2 (2.9) |
| Hematologic involvement, n (%) | 29 (42.0) |
| Hemolytic anemia, n (%) | 5 (7.2) |
| Leukopenia, n (%) | 24 (34.7) |
| Thrombocytopenia, n (%) | 10 (14.5) |
| Interstitial lung disease, n (%) | 5 (7.2) |
| Serositis, n (%) | 3 (4.3) |
| ANA positive, n (%) | 69 (100.0) |
| Anti-dsDNA positive, n (%) | 46 (66.7) |
| Anti-Sm positive, n (%) | 12 (17.3) |
| Anti-nRNP positive, n (%) | 30 (43.4) |
| Anti-SSA positive, n (%) | 35 (50.7) |
| Anti-SSB positive, n (%) | 7 (10.1) |
| Anti-rRNP positive, n (%) | 16 (23.2) |
| Complement 3/(g/L), x±s | 0.64±0.29 |
| Complement 4/(g/L), x±s | 0.12±0.07 |
| IgG/(g/L), x±s | 18.7±7.7 |
| Rheumatoid factor positive, n (%) | 15 (21.7) |
| SLEDAI score, x±s | 10.0±6.2 |